Join
Live feed
·
INSIDERFilingvia Quantisnow
AtriCure Inc. logo

Chief Scientific Officer Doraiswamy Vinayak sold $91,450 worth of shares (2,500 units at $36.58), decreasing direct ownership by 3% to 71,872 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ATRC· AtriCure Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATRC (AtriCure Inc.) and more on Quantisnow.